Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear
- 22 November 2005
- journal article
- Published by Elsevier in Hearing Research
- Vol. 212 (1-2) , 22-32
- https://doi.org/10.1016/j.heares.2005.10.006
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Loop Diuretic Infusion Increases Thiazide-Sensitive Na+/Cl--Cotransporter AbundanceJournal of the American Society of Nephrology, 2001
- Sudden Sensorineural Hearing LossJAMA Otolaryngology–Head & Neck Surgery, 2001
- Specific nongenomic actions of aldosteroneKidney International, 2000
- GLUCOCORTICOID AND MINERALOCORTICOID RECEPTORS: Biology and Clinical RelevanceAnnual Review of Medicine, 1997
- Anti-inflammatory actions of steroids: molecular mechanismsTrends in Pharmacological Sciences, 1993
- Synthesis of new 11.beta.-substituted spirolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptorsJournal of Medicinal Chemistry, 1993
- Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoterEndocrinology, 1992
- Adrenocorticotropin and Cortisol-Induced Changes in Urinary Sodium and Potassium Excretion in Man: Effects of Spironolactone and RU486*Journal of Clinical Endocrinology & Metabolism, 1988
- Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid ReceptorScience, 1987
- Spironolactone: A Glucocorticoid Agonist or Antagonist?Clinical and Experimental Hypertension. Part A: Theory and Practice, 1982